Assembly Biosciences
ASMB
52 hedge funds and large institutions have $118M invested in Assembly Biosciences in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 10 closing their positions.
108% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 12
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 57 → 52 (-5)
49% less capital invested
Capital invested by funds: $232M → $118M (-$114M)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$4.59M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$1.95M |
| 3 |
VAM
Visium Asset Management
New York
|
+$1.47M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$843K |
| 5 |
Morgan Stanley
New York
|
+$750K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
-$3.37M |
| 2 |
HM
HealthCor Management
New York
|
-$2.74M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$1.19M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$1.1M |
| 5 |
OPPM
Opus Point Partners Management
New York
|
-$733K |
ASMB Hedge Fund Activity: Q3 2015 in Review
52 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q3 2015, worth a combined $118M — down 49% from $232M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ASMB and 5 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 25 added.
The largest buyer was EcoR1 Capital, adding an estimated $4.59M. The largest seller was Ghost Tree Capital, exiting entirely with an estimated $3.37M sold.
- 52 institutional investors held Assembly Biosciences (ASMB) as of Q3 2015, down from 57 in Q2 2015.
- Funds reported $118M of Assembly Biosciences stock for Q3 2015, down 49% quarter-over-quarter.
- 5 funds opened new Assembly Biosciences positions in Q3 2015 and 10 closed out, a net change of -5 holders.
- The largest Assembly Biosciences buyer in Q3 2015 was EcoR1 Capital, an estimated $4.59M added.
- The largest Assembly Biosciences seller in Q3 2015 was Ghost Tree Capital, an estimated $3.37M sold.
Based on aggregated 13F filings for Q3 2015.